An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease

Author:

Djokovic Nemanja1,Ruzic Dusan1ORCID,Djikic Teodora1,Cvijic Sandra2,Ignjatovic Jelisaveta2,Ibric Svetlana2,Baralic Katarina3,Buha Djordjevic Aleksandra3,Curcic Marijana3,Djukic‐Cosic Danijela3,Nikolic Katarina1

Affiliation:

1. Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Belgrade Vojvode Stepe 450 11221 Belgrade Serbia

2. Department of Pharmaceutical Technology and Cosmetology University of Belgrade Faculty of Pharmacy Vojvode Stepe 450 11221 Belgrade Serbia

3. Department of Toxicology “Akademik Danilo Soldatovic” Faculty of Pharmacy University of Belgrade Vojvode Stepe 450 11221 Belgrade Serbia

Publisher

Wiley

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,Molecular Medicine,Structural Biology

Reference90 articles.

1. “Coronavirus Update (Live): 94 421 017 Cases and 2 020 254 Deaths from COVID-19 Virus Pandemic - Worldometer ” can be found underhttps://www.worldometers.info/coronavirus/ 2021.

2. COVID-19 and the cardiovascular system

3. COVID-19, ACE2, and the cardiovascular consequences

4. O. of the Commissioner “Pfizer-BioNTech COVID-19 Vaccine ” can be found underhttps://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3